Found 68 matching trials
Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide)
PHASE2This study aims to investigate the efficacy and safety of PET regimen combi...
Location
The Affiliated Hospital of Qingdao University
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
PHASE2Study Objectives
1. Evaluate the efficacy of the combination of thalidomid...
Location
Weill Medical College of Cornell University
The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
PHASE3Both malnutrition and inflammation are associated with death in dialysis pa...
Location
Beth Israel Medical Center
A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
PHASE2This study will use a combination of four oral drugs (thalidomide, cyclopho...
Location
Dana-Farber Cancer Institute
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
PHASE3This study has been designed to evaluate whether "anti-angiogenesis" therap...
Location
University of Arkansas for Medical Sciences/MIRT
Long Term Beta Thalassemia Treatment: Findings From The Extension Period
PHASE2The project, titled "Long Term Beta Thalassemia Treatment: Findings From Th...
Status
Active Not Recruiting
Location
National Institute of blood disease and bone marrow transplant
TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial
PHASE2To explore the effectiveness and safety of thalidomide, cyclophosphamide an...
Location
Peking Union Medical College Hospital
Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
PHASE2Primary Objective:
Evaluate the clinical activity of the RT-PEPC combinati...
Location
Weill Medical College of Cornell University
Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients
NAComparison of the efficacy and safety of microtransplantation and autologou...
Location
Beijing Chaoyang Hospital
Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia
PHASE2Bortezomib/Liposomal doxorubicin (V-DD) is preferred to bortezomib single a...
Location
Beijing Clinical Service Center